Back to Resource Hub Webinar

Capturing Oncology Patients' PRO Data: Key Insights

Signant’s Bill Byrom, PhD, sat down with TransPerfect to discuss the impact of recent FDA draft guidance on instrument selection and measurement strategies for capturing patient-reported outcome (PRO) data in modern oncology trials.

The panelists also shared key considerations for trial designs that reduce patient burdens, examined the potential of item banks and augmentation of current tools, and explained the need for specificity of instruments to support labeling claims.

To tune into more oncology and eCOA expert insights, tune into the webinar recording below.

 

Similar posts

Looking for more insights? Explore related resources.

WHITE PAPER

Leveraging the Power of Data Aggregation

READ THE PAPER
BLOG POST

Optimizing PROs in Oncology Drug Development Recap

VISIT THE BLOG
WEBINAR

Do DCTs Still Offer Clinical Precision in Challenging Patient Populations?

WATCH THE WEBINAR

Get notified on new marketing insights

Here mention the benefits of subscribing